Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diacylglycerol kinase zeta (DGKζ) is an enzyme that phosphorylates diacylglycerol (DAG) to produce phosphatidic acid (PA), thereby regulating the intracellular levels of these two bioactive lipids. It plays a critical role in immune cell signaling, particularly in T-cell receptor (TCR) signaling, acting as a negative regulator. DGKζ resides primarily in the cytosol and translocates to the plasma membrane upon stimulation. Alternative splicing leads to different isoforms with distinct regulatory functions.
Phosphorylates diacylglycerol (DAG) to produce phosphatidic acid (PA).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diacylglycerol kinase zeta (DGKζ).